跨性别患者与凝血专科医生的角色
综述讨论跨性别患者激素治疗中静脉血栓栓塞症(VTE)风险,凝血专科医生常被咨询个体VTE风险,尤其有个人或家族VTE史者。文章回顾常见转诊问题及现有数据与局限性。
要点
- 跨性别医疗以性激素治疗为基础,通常无限期持续,即使 after 性别肯定手术后。
- 激素治疗与多种正面效应及并发症、副作用相关,VTE风险是主要关注点。
- 凝血专科医生需熟悉内分泌治疗目标及当前激素方案的VTE风险。
核心结论
- 凝血专科医生需熟悉跨性别患者内分泌治疗的目标及当前激素方案相关的VTE风险。
研究设计与样本
- 综述,回顾跨性别患者激素治疗的常见转诊问题、现有数据及其局限性,聚焦VTE风险。
主要发现
- 跨性别患者常因个体VTE风险被转诊至凝血专科,尤其存在个人或家族VTE史时。
- 激素治疗与多种正面效应及并发症和副作用相关,VTE风险是主要关注点。
临床怎么用
- 凝血专科医生应熟悉内分泌治疗包括治疗目标及当前激素方案相关的VTE风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The medical care of transgender patients relies on the use of sex hormones to develop and maintain the physical characteristics consistent with gender identity as the first step in transitioning. Hormonal therapy is usually continued indefinitely, even following gender-affirming surgeries. The use of hormonal treatments is associated with a multitude of positive effects as well as complications and side effects. The risk of venous thromboembolism (VTE) is a major concern. Transgender patients are often referred to coagulation specialists for advice regarding an individual patient's risk for VTE, especially if there is a personal or family history of VTE. Coagulation specialists need to be familiar with endocrine therapy including the goals of treatment and the VTE risks associated with currently used hormone regimens. We will review common referral questions and the available data and their limitations for the use of hormonal therapy in transgender patients focusing on the risk of VTE.
引用
- Connors JM, Middeldorp S. Transgender patients and the role of the coagulation clinician. J Thromb Haemost. 2019. PMID: 31465627. doi:10.1111/jth.14626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。